Latest News about IBB
Recent news which mentions IBB
You Don't Have to Pick a Winner in Biotech. Here's Why.
November 18, 2023
Tickers
IBB
From Motley Fool
How much thematic exposure do stock-market investors have? Here’s what BlackRock found.
November 15, 2023
From MarketWatch
Under the Microscope: 3 Biotech Stocks Pioneering Tomorrow’s Cures
November 09, 2023
From InvestorPlace
TG Therapeutics’ stock rockets after blowout earnings
November 01, 2023
From MarketWatch
Moderna’s stock snaps record losing streak as Cathie Wood’s ETF boosts stake by more than $4 million
October 24, 2023
From MarketWatch
Johnson & Johnson Stock: Is Now the Time to Sell?
October 14, 2023
From InvestorPlace
The 3 Best Biotech Stocks to Buy Now: September 2023
September 04, 2023
From InvestorPlace
From Benzinga
5 Meme Stocks to Sell Immediately, According to AI
August 22, 2023
From InvestorPlace
The 3 Most Undervalued Biotech Stocks to Buy Now: August 2023
August 17, 2023
From InvestorPlace
Weight-Loss Drug Wegovy Adds Mass To Novo Nordisk's stock, Pushing Valuation Past Denmark's GDP
August 12, 2023
From Benzinga
From Benzinga
From Motley Fool
From Benzinga
3 Top ETFs to Buy Right Now
July 24, 2023
From Motley Fool
From MarketWatch
3 Biotech Stocks to Avoid Like the Plague
May 23, 2023
From InvestorPlace
Bull vs. Bear: How Healthy Are Biotech ETFs?
May 10, 2023
From ETF Trends
ImmunoGen stock rockets after ovarian cancer treatment shows ‘meaningful’ survival benefit
May 03, 2023
From MarketWatch
VettaFi Voices On: Smart Beta and Equal-Weight ETFs
April 28, 2023
From ETF Trends
Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention
April 13, 2023
From Benzinga
Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules
April 13, 2023
From Benzinga
New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications
April 12, 2023
From Benzinga
Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead
April 11, 2023
From Benzinga
From Benzinga
From Benzinga
Here’s one for the battered bulls: the second-largest sector in the S&P 500 is stirring to life, says this strategist.
March 22, 2023
From MarketWatch
US Judge Weighs Nationwide Ban On Abortion Pills
March 16, 2023
From Benzinga
From InvestorPlace
Silicon Valley Bank Meltdown Hits Healthcare Sector As Well
March 13, 2023
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.